Prevalence of sexual dysfunction among newer antidepressants
Few data are available regarding the safety of combining MS DMTs with other immunomodulatory therapies, presenting a challenge for the treatment of people with MS who have comorbid systemic autoimmune disorders or cancers that require immunomodulatory therapy
PMID: 39344838 Bobrowicz M, et al
Microdosing involves starting with a low dose and increasing to a fraction, up to 25%, of the standard maintenance dose
As these groundbreaking treatments gain popularity, its important to understand how to use them effectively for long-term success
Der Autor ist seit 1998 im Sport aktiv und blickt auf Wettkampferfahrungen im Kampfsport, Powerlifting, Bodybuilding und Marathonlauf zurck